Literature DB >> 17404860

Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Jason Samarasena1, Mark Borgaonkar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404860     DOI: 10.1007/s10620-006-9613-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  22 in total

1.  HCV-associated hepatocellular carcinoma without cirrhosis.

Authors:  A el-Refaie; K Savage; S Bhattacharya; S Khakoo; T J Harrison; M el-Batanony; S Nasr; N Mokhtar; K Amer; P J Scheuer; A P Dhillon
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

2.  Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.

Authors:  B I Korelitz; F J Mirsky; M R Fleisher; J I Warman; N Wisch; G W Gleim
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

3.  Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.

Authors:  C J Chen; L Y Wang; S N Lu; M H Wu; S L You; Y J Zhang; L W Wang; R M Santella
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

4.  Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.

Authors:  A G Fraser; T R Orchard; E M Robinson; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

5.  Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay.

Authors:  Y Ueno; S Nagata; T Tsutsumi; A Hasegawa; M F Watanabe; H D Park; G C Chen; G Chen; S Z Yu
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

6.  Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors:  W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal:  Lancet       Date:  1994-05-21       Impact factor: 79.321

Review 7.  Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.

Authors:  J Romagnuolo; D C Sadowski; E Lalor; L Jewell; A B Thomson
Journal:  Can J Gastroenterol       Date:  1998-10       Impact factor: 3.522

8.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors:  F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

9.  Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.

Authors:  U C Nzeako; Z D Goodman; K G Ishak
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

Review 10.  Malignancy in Crohn's disease.

Authors:  D Bernstein; A Rogers
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

View more
  5 in total

1.  Hepatocellular carcinoma occurring in a Crohn's disease patient.

Authors:  Mitsuaki Ishida; Shigeyuki Naka; Hisanori Shiomi; Tomoyuki Tsujikawa; Akira Andoh; Tamio Nakahara; Yasuharu Saito; Yoshimasa Kurumi; Mikiko Takikita-Suzuki; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.

Authors:  Hiromasa Ohira; Kazumichi Abe; Atsushi Takahashi; Mikio Zeniya; Takafumi Ichida
Journal:  J Gastroenterol       Date:  2012-06-13       Impact factor: 7.527

3.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

4.  Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?

Authors:  Youssef Botros; Mary Mathews; Hiren Patel; Nihar Shah; Walid Baddoura; Andrew de la Torre
Journal:  Case Rep Gastrointest Med       Date:  2015-12-14

5.  Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma.

Authors:  Hongmei Wang; Jianmin Liu; Xuemei Hu; Shanshan Liu; Baojun He
Journal:  Med Sci Monit       Date:  2016-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.